Menu Search
Equities

Inspire Medical Systems Inc

INSP:NYQ

Inspire Medical Systems Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)210.93
  • Today's Change2.54 / 1.22%
  • Shares traded348.70k
  • 1 Year change+3.61%
  • Beta1.3208
Data delayed at least 15 minutes, as of Sep 19 2024 19:33 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Sep-23
  • 20-Jun-24
  • 18-Jul-24
  • 15-Aug-24
  • 12-Sep-24
Select bar for recommendation details.
Recommendations12-Sep-24
Buy2
Outperform10
Hold7
Sell0
Strong Sell0

Share price forecast in USD

The 16 analysts offering 12 month price targets for Inspire Medical Systems Inc have a median target of 225.00, with a high estimate of 270.00 and a low estimate of 170.00. The median estimate represents a 7.97% increase from the last price of 208.39.
High29.6%270.00
Med8.0%225.00
Low-18.4%170.00

Earnings history & estimates in USD

On Aug 06, 2024, Inspire Medical Systems Inc reported 2nd quarter 2024 earnings of 0.32 per share. This result exceeded the -0.14 consensus loss of the 17 analysts covering the company and outperformed last year's 2nd quarter results by 0.73.
The next earnings announcement is expected on Nov 05, 2024.
Average growth rate+29.27%
Inspire Medical Systems Inc reported annual 2023 losses of -0.72 per share on Feb 06, 2024.
Average growth rate+9.12%
More ▼

Revenue history & estimates in USD

Inspire Medical Systems, Inc. had 2nd quarter 2024 revenues of 195.89m. This bettered the 189.46m consensus of the 17 analysts covering the company. This was 53.16% above the prior year's 2nd quarter results.
Average growth rate+7.92%
Inspire Medical Systems, Inc. had revenues for the full year 2023 of 624.80m. This was 53.19% above the prior year's results.
Average growth rate+67.71%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.